Mechanisms of drug resistance: daptomycin resistance

Truc T Tran1,2, Jose M Munita1,2,3, Cesar A Arias1,2,4,5

  • 1Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School at Houston, Houston, Texas.

Insights

Daptomycin resistance in Gram-positive pathogens involves complex genetic pathways and adaptive changes in cell membranes. Understanding these mechanisms is crucial for effective antibiotic therapy against resistant infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Daptomycin (DAP) is a vital antibiotic for Gram-positive infections, including multidrug-resistant strains.
  • Daptomycin resistance (DAP-R) is increasingly reported in key pathogens like Staphylococcus aureus and Enterococcus spp.
  • DAP-R mechanisms are diverse but often linked to cell wall and membrane homeostasis alterations.

Purpose of the Study:

  • To review recent findings on the molecular mechanisms of Daptomycin resistance in Gram-positive pathogens.
  • To discuss the clinical implications of DAP-R for treating severe infections.
  • To provide insights into bacterial cell envelope stress responses.

Main Methods:

  • Literature review of studies on Daptomycin resistance mechanisms.
  • Analysis of genetic pathways and adaptive changes in bacterial physiology.
  • Examination of cell wall and cell membrane homeostasis in resistant strains.

Main Results:

  • Daptomycin resistance is associated with significant adaptive changes in bacterial cell envelope.
  • Mechanisms of DAP-R are complex and involve diverse genetic pathways.
  • Altered cell membrane and cell wall homeostasis are common features of DAP-R.

Conclusions:

  • Understanding DAP-R molecular mechanisms is essential for developing new therapeutic strategies.
  • Adaptive changes in bacterial physiology play a critical role in Daptomycin resistance.
  • Further research is needed to address the clinical challenges posed by DAP-resistant Gram-positive pathogens.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
102
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
34
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
69
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
46